The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Open accessAbstract
Background. Experience from treating patients with Spanish influenza and influenza A(H5N1) suggested that convalescent plasma therapy might be beneficial. However, its efficacy in patients with severe pandemic influenza A(H1N1) 2009 virus (H1N1 2009) infection remained unknown. Methods. During the period from 1 September 2009 through 30 June 2010, we conducted a prospective cohort study by recruiting patients aged ≥18 years with severe H1N1 2009 infection requiring intensive care. Patients were offered treatment with convalescent plasma with a neutralizing antibody titer of ≥1:160, harvested by apheresis from patients recovering from H1N1 2009 infection. Clinical outcome was compared with that of patients who declined plasma treatment as the untreated controls. Results. Ninety-three patients with severe H1N1 2009 infection requiring intensive care were recruited. Twenty patients (21.5%) received plasma treatment. The treatment and control groups were matched by age, sex, and disease severity scores. Mortality in the treatment group was significantly lower than in the nontreatment group (20.0% vs 54.8%; P = .01). Multivariate analysis showed that plasma treatment reduced mortality (odds ratio [OR], .20; 95% confidence interval [CI], .06-.69; P = .011), whereas complication of acute renal failure was independently associated with death (OR, 3.79; 95% CI, 1.15-12.4; P = .028). Subgroup analysis of 44 patients with serial respiratory tract viral load and cytokine level demonstrated that plasma treatment was associated with significantly lower day 3, 5, and 7 viral load, compared with the control group (P < .05). The corresponding temporal levels of interleukin 6, interleukin 10, and tumor necrosis factor α (P < .05) were also lower in the treatment group. Conclusions. Treatment of severe H1N1 2009 infection with convalescent plasma reduced respiratory tract viral load, serum cytokine response, and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome
(2009) · JAMA · doi:10.1001/jama.2009.1535 · Cited by 1,596
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,259
Louie, J. K. (2009) · JAMA · doi:10.1001/jama.2009.1583 · Cited by 1,019
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908481 · Cited by 1,001
Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?
Luke, T. C., Kilbane, E. M., Jackson, J. L., & Hoffman, S. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00139 · Cited by 636
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
Cao, B., Li, X.-W., Mao, Y., Wang, J., Lu, H.-Z., Chen, Y.-S., Liang, Z.-A., Liang, L., Zhang, S.-J., Zhang, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906612 · Cited by 590
Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis
Echevarría-Zuno, S., Mejía-Aranguré, J. M., Mar-Obeso, A. J., Grajales-Muñiz, C., Robles-Pérez, E., González-León, M., Ortega-Alvarez, M. C., Gonzalez-Bonilla, C., Rascón-Pacheco, R. A., & Borja-Aburto, V. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61638-x · Cited by 487
Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
Chu, K. H., Tsang, W. K., Tang, C. S., Lam, M. F., Lai, F. M., To, K. F., Fung, K. S., Tang, H. L., Yan, W. W., Chan, H. W. H., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67130.x · Cited by 483
Self-citationTo, K. K. W., Hung, I. F. N., Li, I. W. S., Lee, K., Koo, C., Yan, W., Liu, R., Ho, K., Chu, K., Watt, C., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650581 · Cited by 419
Self-citationTreatment with Convalescent Plasma for Influenza A (H5N1) Infection
Zhou, B., Zhong, N., & Guan, Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070359 · Cited by 406
Identification of influenza A nucleoprotein as an antiviral target
Kao, R. Y., Yang, D., Lau, L.-S., Tsui, W. H. W., Hu, L., Dai, J., Chan, M.-P., Chan, C.-M., Wang, P., Zheng, B.-J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1638 · Cited by 264
Self-citationYeh, K.-M., Chiueh, T.-S., Siu, L. K., Lin, J.-C., Chan, P. K. S., Peng, M.-Y., Wan, H.-L., Chen, J.-H., Hu, B.-S., Perng, C.-L., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki346 · Cited by 247
Viral load in patients infected with pandemic H1N1 2009 influenza A virus
To, K. K. W., Chan, K., Li, I. W. S., Tsang, T., Tse, H., Chan, J. F. W., Hung, I. F. N., Lai, S., Leung, C., Kwan, Y., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21664 · Cited by 226
Self-citationProphylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza
Simmons, C. P., Bernasconi, N. L., Suguitan, A. L., Mills, K., Ward, J. M., Chau, N. V. V., Hien, T. T., Sallusto, F., Ha, D. Q., Farrar, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040178 · Cited by 208
The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong
Wu, J. T., Ma, E. S. K., Lee, C. K., Chu, D. K. W., Ho, P., Shen, A. L., Ho, A., Hung, I. F. N., Riley, S., Ho, L. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656740 · Cited by 191
Self-citationMemoli, M. J., Hagey, R. J., Hassantoufighi, A., Eichelberger, M. C., & Taubenberger, J. K. (2010) · Clinical Infectious Diseases · doi:10.1086/651605 · Cited by 154
Hark back: Passive immunotherapy for influenza and other serious infections
Luke, T. C., Casadevall, A., Watowich, S. J., Hoffman, S. L., Beigel, J. H., & Burgess, T. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d44c1e · Cited by 150
Song, J. Y., Cheong, H. J., Hwang, I. S., Choi, W. S., Jo, Y. M., Park, D. W., Cho, G. J., Hwang, T. G., & Kim, W. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.067 · Cited by 143
Hanson, B. J., Boon, A. C. M., Lim, A. P., Webb, A., Ooi, E. E., & Webby, R. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-126 · Cited by 110
Li, I. W. S., Hung, I. F., To, K. K., Chan, K., Wong, S. S. Y., Chan, J. F., Cheng, V. C., Tsang, O. T.-Y., Lai, S.-T., Lau, Y., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-3072 · Cited by 105
Self-citationOseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
Chen, H., Cheung, C. L., Tai, H., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1512.091057 · Cited by 93
Shiley, K. T., Nadolski, G., Mickus, T. J., Fishman, N. O., & Lautenbach, E. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/653204 · Cited by 65
Chang, Y., van Hal, S. J., Spencer, P. M., Gosbell, I. B., & Collett, P. W. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03426.x · Cited by 62
Magro, M., Andreu, D., Gómez‐Puertas, P., Melero, J. A., & Palomo, C. (2010) · Journal of Virology · doi:10.1128/jvi.00447-10 · Cited by 59
To, K. K., Wong, S. S. Y., Li, I. W. S., Hung, I. F., Tse, H., Woo, P. C. Y., Chan, K., & Yuen, K. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.096206 · Cited by 59
Self-citationIntravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus
Härter, G., Zimmermann, O., Maier, L., Schubert, A., Mertens, T., Kern, P., & Wöhrle, J. (2010) · Clinical Infectious Diseases · doi:10.1086/651604 · Cited by 45
Lau, S. K. P., Chan, K., Yip, C. C. Y., Ng, T. K., Tsang, O. T. Y., Woo, P. C. Y., & Yuen, K. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00924-09 · Cited by 44
Self-citationWu, J. T. K., Lee, C. K., Cowling, B. J., & Yuen, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911596107 · Cited by 35
Self-citationSubramony, H., Lai, F. Y., Ang, L. W., Cutter, J. L., Lim, P. L., & James, L. (2010) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v39n4p283 · Cited by 27
Cited by
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
The cytokine storm and COVID-19
Hu, B., Huang, S., & Yin, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26232 · Cited by 1,655
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Neutralizing monoclonal antibodies for treatment of COVID-19
Taylor, P. C., Adams, A. C., Hufford, M. M., de la Torre, I., Winthrop, K., & Gottlieb, R. L. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00542-x · Cited by 732
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
Self-citation
Metadata
- Authors
- Hung, I. F., To, K. K., Lee, C.-K., Lee, K.-L., Chan, K., Yan, W.-W., Liu, R., Watt, C.-L., Chan, W.-M., Lai, K.-Y., Koo, C.-K., Buckley, T., Chow, F.-L., Wong, K.-K., Chan, H.-S., Ching, C.-K., Tang, B. S., Lau, C. C., Li, I. W., Liu, S.-H., Chan, K.-H., Lin, C.-K., & Yuen, K.-Y.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-15
- Volume
- 52
- Issue
- 4
- Pages
- 447-456
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2096238447
- Cited by
- 678
- References
- 30
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.